Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide-Reference-Cited by-同舟云学术

Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide

Published:2008-08-15 Issue:16 Volume:65 Page:1552-1555
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Ip Eric J.¹,Lee-Ma Annette²,Troxell Lawrence S.³,Chan James⁴

Affiliation:

1. Department of Clinical Sciences, Touro University College of Pharmacy, Vallejo, CA, and Diabetes Specialist and Clinical Pharmacist, Department of Internal Medicine, Kaiser Permanente Mountain View Medical Offices, Mountain View, CA; at the time of writing, he was Pharmacy Practice Resident, Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA

2. Oncology Pharmacy Department

3. Ambulatory Care Clinical Pharmacy, Kaiser Permanente Santa Clara Medical Center

4. Pharmacy Outcomes Research Group, Kaiser Permanente, Oakland, CA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/65/16/1552/28304002/ajhp1552.pdf

Reference18 articles.

1. Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium

2. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.